OCZYESA XR DIN 02572451
Status: Approved
Holder: CAMURUS AB
Health Canada record
| Active ingredient(s) | OCTREOTIDE (OCTREOTIDE HYDROCHLORIDE) 20 MG |
|---|
| Dosage form | Solution (Extended-Release) |
|---|
| Route | Subcutaneous |
|---|
| Schedule | PRESCRIPTION |
|---|
| Class | Human |
|---|
| ATC | H01CB02 OCTREOTIDE |
|---|
| Original market date | |
|---|
| Current status date | 08-Oct-2026 |
|---|
| Source | Health Canada DPD |
|---|
No Canadian shortage report is currently matched to this DIN.
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|
| 38433 | 2026-10-08 | New Drug Submission (NDS) | |
Request a quote for OCZYESA XR
How to read a Canadian DIN record